nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—Amitriptyline—migraine	0.541	1	CrCtD
Olopatadine—Nortriptyline—Amitriptyline—migraine	0.0458	0.156	CrCrCtD
Olopatadine—Thiothixene—Amitriptyline—migraine	0.0413	0.141	CrCrCtD
Olopatadine—Doxepin—Amitriptyline—migraine	0.0413	0.141	CrCrCtD
Olopatadine—Cyclobenzaprine—Amitriptyline—migraine	0.0389	0.132	CrCrCtD
Olopatadine—Dimetindene—Amitriptyline—migraine	0.0377	0.128	CrCrCtD
Olopatadine—Clomipramine—Amitriptyline—migraine	0.0309	0.105	CrCrCtD
Olopatadine—Imipramine—Amitriptyline—migraine	0.029	0.0985	CrCrCtD
Olopatadine—Chlorprothixene—Amitriptyline—migraine	0.029	0.0985	CrCrCtD
Olopatadine—HRH1—Amitriptyline—migraine	0.0259	0.457	CbGbCtD
Olopatadine—CYP3A4—Propranolol—migraine	0.00762	0.134	CbGbCtD
Olopatadine—CYP3A4—Amitriptyline—migraine	0.00659	0.116	CbGbCtD
Olopatadine—CYP3A4—Valproic Acid—migraine	0.00601	0.106	CbGbCtD
Olopatadine—CYP3A4—Topiramate—migraine	0.00542	0.0954	CbGbCtD
Olopatadine—CYP3A4—Verapamil—migraine	0.00523	0.092	CbGbCtD
Olopatadine—S100B—peripheral nervous system—migraine	0.00331	0.108	CbGeAlD
Olopatadine—S100B—nerve—migraine	0.00258	0.084	CbGeAlD
Olopatadine—S100B—blood vessel—migraine	0.00203	0.066	CbGeAlD
Olopatadine—S100A1—neck—migraine	0.00168	0.0546	CbGeAlD
Olopatadine—S100A13—neck—migraine	0.00149	0.0485	CbGeAlD
Olopatadine—S100A1—trigeminal ganglion—migraine	0.00145	0.0472	CbGeAlD
Olopatadine—S100A12—trigeminal ganglion—migraine	0.00127	0.0413	CbGeAlD
Olopatadine—S100B—brainstem—migraine	0.00111	0.0361	CbGeAlD
Olopatadine—S100A13—Alprenolol—Propranolol—migraine	0.00105	1	CbGdCrCtD
Olopatadine—S100A1—cardiovascular system—migraine	0.00105	0.0341	CbGeAlD
Olopatadine—S100A13—cardiovascular system—migraine	0.000929	0.0302	CbGeAlD
Olopatadine—S100A12—cardiovascular system—migraine	0.000917	0.0298	CbGeAlD
Olopatadine—S100B—cardiovascular system—migraine	0.000905	0.0294	CbGeAlD
Olopatadine—S100A2—head—migraine	0.00077	0.0251	CbGeAlD
Olopatadine—S100A1—head—migraine	0.000709	0.0231	CbGeAlD
Olopatadine—S100A1—nervous system—migraine	0.000672	0.0219	CbGeAlD
Olopatadine—S100A1—central nervous system—migraine	0.000647	0.0211	CbGeAlD
Olopatadine—S100A1—cerebellum—migraine	0.000633	0.0206	CbGeAlD
Olopatadine—S100A13—head—migraine	0.000629	0.0205	CbGeAlD
Olopatadine—S100A12—head—migraine	0.000621	0.0202	CbGeAlD
Olopatadine—S100B—head—migraine	0.000613	0.0199	CbGeAlD
Olopatadine—S100A13—nervous system—migraine	0.000597	0.0194	CbGeAlD
Olopatadine—S100B—nervous system—migraine	0.000581	0.0189	CbGeAlD
Olopatadine—S100A13—central nervous system—migraine	0.000574	0.0187	CbGeAlD
Olopatadine—S100A13—cerebellum—migraine	0.000561	0.0183	CbGeAlD
Olopatadine—S100B—central nervous system—migraine	0.000559	0.0182	CbGeAlD
Olopatadine—S100A2—brain—migraine	0.000558	0.0182	CbGeAlD
Olopatadine—S100B—cerebellum—migraine	0.000547	0.0178	CbGeAlD
Olopatadine—S100A1—brain—migraine	0.000514	0.0167	CbGeAlD
Olopatadine—S100A13—brain—migraine	0.000456	0.0148	CbGeAlD
Olopatadine—S100B—Nuclear signaling by ERBB4—PGR—migraine	0.00045	0.0609	CbGpPWpGaD
Olopatadine—S100A12—brain—migraine	0.00045	0.0146	CbGeAlD
Olopatadine—S100B—brain—migraine	0.000444	0.0144	CbGeAlD
Olopatadine—HRH1—trigeminal ganglion—migraine	0.000257	0.00836	CbGeAlD
Olopatadine—HRH1—Monoamine GPCRs—HTR1D—migraine	0.00025	0.0338	CbGpPWpGaD
Olopatadine—S100B—Nuclear signaling by ERBB4—ESR1—migraine	0.00024	0.0325	CbGpPWpGaD
Olopatadine—HRH1—Monoamine GPCRs—HTR2B—migraine	0.000233	0.0314	CbGpPWpGaD
Olopatadine—HRH1—Amine ligand-binding receptors—HTR1D—migraine	0.00021	0.0284	CbGpPWpGaD
Olopatadine—HRH1—Amine ligand-binding receptors—HTR2B—migraine	0.000196	0.0264	CbGpPWpGaD
Olopatadine—Influenza—Valproic Acid—migraine	0.00019	0.00286	CcSEcCtD
Olopatadine—Clomipramine—HTR2B—migraine	0.000187	0.0647	CrCbGaD
Olopatadine—Chlorprothixene—HTR2B—migraine	0.000186	0.0644	CrCbGaD
Olopatadine—Somnolence—Amitriptyline—migraine	0.000181	0.00272	CcSEcCtD
Olopatadine—Muscle spasms—Verapamil—migraine	0.00018	0.0027	CcSEcCtD
Olopatadine—Cough—Propranolol—migraine	0.000177	0.00266	CcSEcCtD
Olopatadine—Vision blurred—Verapamil—migraine	0.000176	0.00264	CcSEcCtD
Olopatadine—Fatigue—Amitriptyline—migraine	0.000175	0.00264	CcSEcCtD
Olopatadine—Nasopharyngitis—Timolol—migraine	0.000175	0.00263	CcSEcCtD
Olopatadine—Weight increased—Valproic Acid—migraine	0.000173	0.0026	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.000172	0.00258	CcSEcCtD
Olopatadine—Eye pain—Topiramate—migraine	0.00017	0.00255	CcSEcCtD
Olopatadine—Depression—Valproic Acid—migraine	0.000169	0.00254	CcSEcCtD
Olopatadine—Feeling abnormal—Amitriptyline—migraine	0.000168	0.00252	CcSEcCtD
Olopatadine—Dry skin—Gabapentin—migraine	0.000167	0.00251	CcSEcCtD
Olopatadine—Urinary tract infection—Valproic Acid—migraine	0.000165	0.00247	CcSEcCtD
Olopatadine—Conjunctivitis—Valproic Acid—migraine	0.000165	0.00247	CcSEcCtD
Olopatadine—Infection—Propranolol—migraine	0.000165	0.00247	CcSEcCtD
Olopatadine—Doxepin—HTR2B—migraine	0.000164	0.0568	CrCbGaD
Olopatadine—Nasopharyngitis—Gabapentin—migraine	0.000163	0.00245	CcSEcCtD
Olopatadine—Nervous system disorder—Propranolol—migraine	0.000162	0.00244	CcSEcCtD
Olopatadine—Visual disturbance—Topiramate—migraine	0.000162	0.00243	CcSEcCtD
Olopatadine—Thirst—Topiramate—migraine	0.000161	0.00242	CcSEcCtD
Olopatadine—Skin disorder—Propranolol—migraine	0.000161	0.00242	CcSEcCtD
Olopatadine—Body temperature increased—Amitriptyline—migraine	0.000161	0.00242	CcSEcCtD
Olopatadine—Epistaxis—Valproic Acid—migraine	0.00016	0.0024	CcSEcCtD
Olopatadine—Sinusitis—Valproic Acid—migraine	0.000159	0.00239	CcSEcCtD
Olopatadine—Influenza—Gabapentin—migraine	0.000158	0.00237	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Timolol—migraine	0.000157	0.00236	CcSEcCtD
Olopatadine—Discomfort—Verapamil—migraine	0.000157	0.00236	CcSEcCtD
Olopatadine—Dry mouth—Verapamil—migraine	0.000155	0.00234	CcSEcCtD
Olopatadine—Rhinitis—Valproic Acid—migraine	0.000152	0.00229	CcSEcCtD
Olopatadine—Oedema—Verapamil—migraine	0.000152	0.00229	CcSEcCtD
Olopatadine—S100B—Signaling by ERBB4—PGR—migraine	0.000152	0.0205	CbGpPWpGaD
Olopatadine—HRH1—Monoamine GPCRs—HTR1B—migraine	0.000152	0.0205	CbGpPWpGaD
Olopatadine—Infection—Verapamil—migraine	0.000151	0.00228	CcSEcCtD
Olopatadine—Hypoaesthesia—Valproic Acid—migraine	0.000151	0.00227	CcSEcCtD
Olopatadine—Pharyngitis—Valproic Acid—migraine	0.000151	0.00227	CcSEcCtD
Olopatadine—Depression—Timolol—migraine	0.00015	0.00226	CcSEcCtD
Olopatadine—Dyspnoea—Propranolol—migraine	0.000148	0.00222	CcSEcCtD
Olopatadine—Somnolence—Propranolol—migraine	0.000147	0.00221	CcSEcCtD
Olopatadine—Conjunctivitis—Timolol—migraine	0.000147	0.0022	CcSEcCtD
Olopatadine—Visual impairment—Valproic Acid—migraine	0.000147	0.0022	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Gabapentin—migraine	0.000146	0.0022	CcSEcCtD
Olopatadine—Asthenia—Amitriptyline—migraine	0.000146	0.00219	CcSEcCtD
Olopatadine—HRH1—Monoamine GPCRs—HTR1A—migraine	0.000146	0.0197	CbGpPWpGaD
Olopatadine—Pruritus—Amitriptyline—migraine	0.000144	0.00216	CcSEcCtD
Olopatadine—Weight increased—Gabapentin—migraine	0.000143	0.00215	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Propranolol—migraine	0.000143	0.00215	CcSEcCtD
Olopatadine—Fatigue—Propranolol—migraine	0.000143	0.00215	CcSEcCtD
Olopatadine—Epistaxis—Timolol—migraine	0.000142	0.00214	CcSEcCtD
Olopatadine—Eye disorder—Valproic Acid—migraine	0.000142	0.00214	CcSEcCtD
Olopatadine—Pain—Propranolol—migraine	0.000142	0.00213	CcSEcCtD
Olopatadine—Sinusitis—Timolol—migraine	0.000141	0.00213	CcSEcCtD
Olopatadine—HRH1—Monoamine GPCRs—HTR2C—migraine	0.000141	0.0191	CbGpPWpGaD
Olopatadine—Infestation NOS—Gabapentin—migraine	0.00014	0.00211	CcSEcCtD
Olopatadine—Infestation—Gabapentin—migraine	0.00014	0.00211	CcSEcCtD
Olopatadine—Depression—Gabapentin—migraine	0.00014	0.0021	CcSEcCtD
Olopatadine—Diarrhoea—Amitriptyline—migraine	0.000139	0.00209	CcSEcCtD
Olopatadine—Immune system disorder—Valproic Acid—migraine	0.000137	0.00206	CcSEcCtD
Olopatadine—Nasopharyngitis—Topiramate—migraine	0.000137	0.00206	CcSEcCtD
Olopatadine—Mediastinal disorder—Valproic Acid—migraine	0.000137	0.00206	CcSEcCtD
Olopatadine—Urinary tract infection—Gabapentin—migraine	0.000137	0.00205	CcSEcCtD
Olopatadine—Conjunctivitis—Gabapentin—migraine	0.000137	0.00205	CcSEcCtD
Olopatadine—Dyspnoea—Verapamil—migraine	0.000136	0.00204	CcSEcCtD
Olopatadine—S100A12—TRAF6 Mediated Induction of proinflammatory cytokines—FOS—migraine	0.000136	0.0184	CbGpPWpGaD
Olopatadine—Rhinitis—Timolol—migraine	0.000136	0.00204	CcSEcCtD
Olopatadine—Somnolence—Verapamil—migraine	0.000135	0.00204	CcSEcCtD
Olopatadine—Gastrointestinal pain—Propranolol—migraine	0.000135	0.00204	CcSEcCtD
Olopatadine—Dizziness—Amitriptyline—migraine	0.000135	0.00202	CcSEcCtD
Olopatadine—Epistaxis—Gabapentin—migraine	0.000132	0.00199	CcSEcCtD
Olopatadine—Sinusitis—Gabapentin—migraine	0.000132	0.00198	CcSEcCtD
Olopatadine—Fatigue—Verapamil—migraine	0.000131	0.00197	CcSEcCtD
Olopatadine—Abdominal pain—Propranolol—migraine	0.000131	0.00197	CcSEcCtD
Olopatadine—Body temperature increased—Propranolol—migraine	0.000131	0.00197	CcSEcCtD
Olopatadine—Visual impairment—Timolol—migraine	0.00013	0.00196	CcSEcCtD
Olopatadine—Pain—Verapamil—migraine	0.00013	0.00196	CcSEcCtD
Olopatadine—Dysgeusia—Valproic Acid—migraine	0.00013	0.00195	CcSEcCtD
Olopatadine—Vomiting—Amitriptyline—migraine	0.000129	0.00194	CcSEcCtD
Olopatadine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—FOS—migraine	0.000128	0.0174	CbGpPWpGaD
Olopatadine—Rash—Amitriptyline—migraine	0.000128	0.00193	CcSEcCtD
Olopatadine—Amitriptyline—HTR1D—migraine	0.000128	0.0444	CrCbGaD
Olopatadine—Dermatitis—Amitriptyline—migraine	0.000128	0.00193	CcSEcCtD
Olopatadine—Back pain—Valproic Acid—migraine	0.000128	0.00192	CcSEcCtD
Olopatadine—Headache—Amitriptyline—migraine	0.000127	0.00192	CcSEcCtD
Olopatadine—HRH1—Amine ligand-binding receptors—HTR1B—migraine	0.000127	0.0172	CbGpPWpGaD
Olopatadine—Muscle spasms—Valproic Acid—migraine	0.000127	0.00191	CcSEcCtD
Olopatadine—Eye disorder—Timolol—migraine	0.000127	0.0019	CcSEcCtD
Olopatadine—Rhinitis—Gabapentin—migraine	0.000126	0.0019	CcSEcCtD
Olopatadine—HRH1—head—migraine	0.000126	0.00409	CbGeAlD
Olopatadine—Feeling abnormal—Verapamil—migraine	0.000126	0.00189	CcSEcCtD
Olopatadine—Hypoaesthesia—Gabapentin—migraine	0.000125	0.00189	CcSEcCtD
Olopatadine—Pharyngitis—Gabapentin—migraine	0.000125	0.00188	CcSEcCtD
Olopatadine—Vision blurred—Valproic Acid—migraine	0.000125	0.00188	CcSEcCtD
Olopatadine—HRH1—Monoamine GPCRs—HTR7—migraine	0.000123	0.0167	CbGpPWpGaD
Olopatadine—Upper respiratory tract infection—Topiramate—migraine	0.000123	0.00185	CcSEcCtD
Olopatadine—Ill-defined disorder—Valproic Acid—migraine	0.000123	0.00185	CcSEcCtD
Olopatadine—S100A12—MyD88 cascade initiated on plasma membrane—FOS—migraine	0.000123	0.0166	CbGpPWpGaD
Olopatadine—HRH1—Amine ligand-binding receptors—HTR1A—migraine	0.000123	0.0166	CbGpPWpGaD
Olopatadine—Immune system disorder—Timolol—migraine	0.000122	0.00184	CcSEcCtD
Olopatadine—Hypersensitivity—Propranolol—migraine	0.000122	0.00183	CcSEcCtD
Olopatadine—Mediastinal disorder—Timolol—migraine	0.000122	0.00183	CcSEcCtD
Olopatadine—S100A12—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—FOS—migraine	0.000122	0.0165	CbGpPWpGaD
Olopatadine—Visual impairment—Gabapentin—migraine	0.000122	0.00183	CcSEcCtD
Olopatadine—Nausea—Amitriptyline—migraine	0.000121	0.00182	CcSEcCtD
Olopatadine—Weight increased—Topiramate—migraine	0.000121	0.00181	CcSEcCtD
Olopatadine—S100A12—MyD88 dependent cascade initiated on endosome—FOS—migraine	0.000119	0.0162	CbGpPWpGaD
Olopatadine—Malaise—Valproic Acid—migraine	0.000119	0.00179	CcSEcCtD
Olopatadine—HRH1—nervous system—migraine	0.000119	0.00388	CbGeAlD
Olopatadine—Asthenia—Propranolol—migraine	0.000119	0.00179	CcSEcCtD
Olopatadine—HRH1—Amine ligand-binding receptors—HTR2C—migraine	0.000118	0.016	CbGpPWpGaD
Olopatadine—Infestation—Topiramate—migraine	0.000118	0.00178	CcSEcCtD
Olopatadine—Infestation NOS—Topiramate—migraine	0.000118	0.00178	CcSEcCtD
Olopatadine—Erythema—Timolol—migraine	0.000118	0.00177	CcSEcCtD
Olopatadine—Eye disorder—Gabapentin—migraine	0.000118	0.00177	CcSEcCtD
Olopatadine—Depression—Topiramate—migraine	0.000118	0.00177	CcSEcCtD
Olopatadine—Acepromazine—HTR1A—migraine	0.000117	0.0404	CrCbGaD
Olopatadine—S100B—MyD88 cascade initiated on plasma membrane—FOS—migraine	0.000116	0.0157	CbGpPWpGaD
Olopatadine—Thiothixene—HTR2C—migraine	0.000116	0.04	CrCbGaD
Olopatadine—Cough—Valproic Acid—migraine	0.000116	0.00174	CcSEcCtD
Olopatadine—Dysgeusia—Timolol—migraine	0.000115	0.00173	CcSEcCtD
Olopatadine—S100A12—Toll Like Receptor 9 (TLR9) Cascade—FOS—migraine	0.000115	0.0156	CbGpPWpGaD
Olopatadine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—FOS—migraine	0.000115	0.0156	CbGpPWpGaD
Olopatadine—Conjunctivitis—Topiramate—migraine	0.000115	0.00173	CcSEcCtD
Olopatadine—Urinary tract infection—Topiramate—migraine	0.000115	0.00173	CcSEcCtD
Olopatadine—HRH1—central nervous system—migraine	0.000115	0.00373	CbGeAlD
Olopatadine—Immune system disorder—Gabapentin—migraine	0.000114	0.00171	CcSEcCtD
Olopatadine—Mediastinal disorder—Gabapentin—migraine	0.000114	0.00171	CcSEcCtD
Olopatadine—Diarrhoea—Propranolol—migraine	0.000113	0.0017	CcSEcCtD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—FOS—migraine	0.000113	0.0153	CbGpPWpGaD
Olopatadine—S100B—MyD88 dependent cascade initiated on endosome—FOS—migraine	0.000113	0.0153	CbGpPWpGaD
Olopatadine—Thiothixene—HTR1A—migraine	0.000112	0.0389	CrCbGaD
Olopatadine—Hypersensitivity—Verapamil—migraine	0.000112	0.00169	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000112	0.00168	CcSEcCtD
Olopatadine—Epistaxis—Topiramate—migraine	0.000111	0.00167	CcSEcCtD
Olopatadine—Discomfort—Valproic Acid—migraine	0.000111	0.00167	CcSEcCtD
Olopatadine—Vision blurred—Timolol—migraine	0.000111	0.00167	CcSEcCtD
Olopatadine—Sinusitis—Topiramate—migraine	0.000111	0.00167	CcSEcCtD
Olopatadine—Cyclobenzaprine—HTR2A—migraine	0.000111	0.0384	CrCbGaD
Olopatadine—Dry mouth—Valproic Acid—migraine	0.00011	0.00166	CcSEcCtD
Olopatadine—Erythema—Gabapentin—migraine	0.00011	0.00165	CcSEcCtD
Olopatadine—Dizziness—Propranolol—migraine	0.00011	0.00165	CcSEcCtD
Olopatadine—Asthenia—Verapamil—migraine	0.000109	0.00164	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 9 (TLR9) Cascade—FOS—migraine	0.000109	0.0147	CbGpPWpGaD
Olopatadine—S100A12—MyD88-independent cascade—FOS—migraine	0.000109	0.0147	CbGpPWpGaD
Olopatadine—Oedema—Valproic Acid—migraine	0.000108	0.00162	CcSEcCtD
Olopatadine—Pruritus—Verapamil—migraine	0.000108	0.00162	CcSEcCtD
Olopatadine—Dysgeusia—Gabapentin—migraine	0.000107	0.00162	CcSEcCtD
Olopatadine—Infection—Valproic Acid—migraine	0.000107	0.00161	CcSEcCtD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—FOS—migraine	0.000107	0.0145	CbGpPWpGaD
Olopatadine—Rhinitis—Topiramate—migraine	0.000106	0.0016	CcSEcCtD
Olopatadine—Back pain—Gabapentin—migraine	0.000106	0.0016	CcSEcCtD
Olopatadine—Nervous system disorder—Valproic Acid—migraine	0.000106	0.00159	CcSEcCtD
Olopatadine—Hypoaesthesia—Topiramate—migraine	0.000106	0.00159	CcSEcCtD
Olopatadine—Muscle spasms—Gabapentin—migraine	0.000106	0.00159	CcSEcCtD
Olopatadine—Vomiting—Propranolol—migraine	0.000105	0.00158	CcSEcCtD
Olopatadine—Pharyngitis—Topiramate—migraine	0.000105	0.00158	CcSEcCtD
Olopatadine—Skin disorder—Valproic Acid—migraine	0.000105	0.00158	CcSEcCtD
Olopatadine—Rash—Propranolol—migraine	0.000104	0.00157	CcSEcCtD
Olopatadine—Dermatitis—Propranolol—migraine	0.000104	0.00157	CcSEcCtD
Olopatadine—Diarrhoea—Verapamil—migraine	0.000104	0.00157	CcSEcCtD
Olopatadine—HRH1—Amine ligand-binding receptors—HTR7—migraine	0.000104	0.014	CbGpPWpGaD
Olopatadine—Vision blurred—Gabapentin—migraine	0.000103	0.00155	CcSEcCtD
Olopatadine—Cough—Timolol—migraine	0.000103	0.00155	CcSEcCtD
Olopatadine—S100B—MyD88-independent cascade—FOS—migraine	0.000103	0.0139	CbGpPWpGaD
Olopatadine—Visual impairment—Topiramate—migraine	0.000102	0.00154	CcSEcCtD
Olopatadine—Ill-defined disorder—Gabapentin—migraine	0.000102	0.00153	CcSEcCtD
Olopatadine—Dizziness—Verapamil—migraine	0.000101	0.00151	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	9.96e-05	0.0015	CcSEcCtD
Olopatadine—Discomfort—Timolol—migraine	9.91e-05	0.00149	CcSEcCtD
Olopatadine—Eye disorder—Topiramate—migraine	9.91e-05	0.00149	CcSEcCtD
Olopatadine—Malaise—Gabapentin—migraine	9.9e-05	0.00149	CcSEcCtD
Olopatadine—Nausea—Propranolol—migraine	9.84e-05	0.00148	CcSEcCtD
Olopatadine—Dry mouth—Timolol—migraine	9.81e-05	0.00147	CcSEcCtD
Olopatadine—S100A12—Activated TLR4 signalling—FOS—migraine	9.78e-05	0.0132	CbGpPWpGaD
Olopatadine—Vomiting—Verapamil—migraine	9.69e-05	0.00146	CcSEcCtD
Olopatadine—Dyspnoea—Valproic Acid—migraine	9.63e-05	0.00145	CcSEcCtD
Olopatadine—Oedema—Timolol—migraine	9.62e-05	0.00145	CcSEcCtD
Olopatadine—Rash—Verapamil—migraine	9.61e-05	0.00144	CcSEcCtD
Olopatadine—Somnolence—Valproic Acid—migraine	9.61e-05	0.00144	CcSEcCtD
Olopatadine—Dermatitis—Verapamil—migraine	9.6e-05	0.00144	CcSEcCtD
Olopatadine—Immune system disorder—Topiramate—migraine	9.58e-05	0.00144	CcSEcCtD
Olopatadine—Cough—Gabapentin—migraine	9.58e-05	0.00144	CcSEcCtD
Olopatadine—Mediastinal disorder—Topiramate—migraine	9.56e-05	0.00144	CcSEcCtD
Olopatadine—Infection—Timolol—migraine	9.56e-05	0.00144	CcSEcCtD
Olopatadine—Headache—Verapamil—migraine	9.55e-05	0.00143	CcSEcCtD
Olopatadine—Nervous system disorder—Timolol—migraine	9.43e-05	0.00142	CcSEcCtD
Olopatadine—Skin disorder—Timolol—migraine	9.34e-05	0.0014	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Valproic Acid—migraine	9.33e-05	0.0014	CcSEcCtD
Olopatadine—Fatigue—Valproic Acid—migraine	9.32e-05	0.0014	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	9.28e-05	0.00139	CcSEcCtD
Olopatadine—S100B—Activated TLR4 signalling—FOS—migraine	9.25e-05	0.0125	CbGpPWpGaD
Olopatadine—Pain—Valproic Acid—migraine	9.24e-05	0.00139	CcSEcCtD
Olopatadine—Erythema—Topiramate—migraine	9.23e-05	0.00139	CcSEcCtD
Olopatadine—Discomfort—Gabapentin—migraine	9.23e-05	0.00139	CcSEcCtD
Olopatadine—CYP3A4—nervous system—migraine	9.21e-05	0.003	CbGeAlD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—FOS—migraine	9.2e-05	0.0124	CbGpPWpGaD
Olopatadine—Clomipramine—HTR2C—migraine	9.14e-05	0.0316	CrCbGaD
Olopatadine—Dry mouth—Gabapentin—migraine	9.14e-05	0.00137	CcSEcCtD
Olopatadine—HRH1—brain—migraine	9.1e-05	0.00296	CbGeAlD
Olopatadine—Chlorprothixene—HTR2C—migraine	9.1e-05	0.0315	CrCbGaD
Olopatadine—Nausea—Verapamil—migraine	9.05e-05	0.00136	CcSEcCtD
Olopatadine—Dysgeusia—Topiramate—migraine	9.04e-05	0.00136	CcSEcCtD
Olopatadine—Oedema—Gabapentin—migraine	8.96e-05	0.00135	CcSEcCtD
Olopatadine—Nortriptyline—HTR2C—migraine	8.93e-05	0.0309	CrCbGaD
Olopatadine—Back pain—Topiramate—migraine	8.93e-05	0.00134	CcSEcCtD
Olopatadine—Feeling abnormal—Valproic Acid—migraine	8.9e-05	0.00134	CcSEcCtD
Olopatadine—Infection—Gabapentin—migraine	8.9e-05	0.00134	CcSEcCtD
Olopatadine—Muscle spasms—Topiramate—migraine	8.88e-05	0.00133	CcSEcCtD
Olopatadine—CYP3A4—central nervous system—migraine	8.87e-05	0.00288	CbGeAlD
Olopatadine—Gastrointestinal pain—Valproic Acid—migraine	8.84e-05	0.00133	CcSEcCtD
Olopatadine—Nervous system disorder—Gabapentin—migraine	8.78e-05	0.00132	CcSEcCtD
Olopatadine—Vision blurred—Topiramate—migraine	8.7e-05	0.00131	CcSEcCtD
Olopatadine—Skin disorder—Gabapentin—migraine	8.7e-05	0.00131	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—FOS—migraine	8.7e-05	0.0118	CbGpPWpGaD
Olopatadine—Nortriptyline—HTR1A—migraine	8.67e-05	0.03	CrCbGaD
Olopatadine—HRH1—Monoamine GPCRs—HTR2A—migraine	8.64e-05	0.0117	CbGpPWpGaD
Olopatadine—Dyspnoea—Timolol—migraine	8.58e-05	0.00129	CcSEcCtD
Olopatadine—Ill-defined disorder—Topiramate—migraine	8.57e-05	0.00129	CcSEcCtD
Olopatadine—Somnolence—Timolol—migraine	8.55e-05	0.00129	CcSEcCtD
Olopatadine—Abdominal pain—Valproic Acid—migraine	8.54e-05	0.00128	CcSEcCtD
Olopatadine—Body temperature increased—Valproic Acid—migraine	8.54e-05	0.00128	CcSEcCtD
Olopatadine—Malaise—Topiramate—migraine	8.33e-05	0.00125	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Timolol—migraine	8.3e-05	0.00125	CcSEcCtD
Olopatadine—Fatigue—Timolol—migraine	8.29e-05	0.00125	CcSEcCtD
Olopatadine—Pain—Timolol—migraine	8.23e-05	0.00124	CcSEcCtD
Olopatadine—S100A12—Toll-Like Receptors Cascades—FOS—migraine	8.19e-05	0.0111	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—ESR1—migraine	8.1e-05	0.0109	CbGpPWpGaD
Olopatadine—Cough—Topiramate—migraine	8.06e-05	0.00121	CcSEcCtD
Olopatadine—Doxepin—HTR2C—migraine	8.02e-05	0.0277	CrCbGaD
Olopatadine—Dyspnoea—Gabapentin—migraine	7.99e-05	0.0012	CcSEcCtD
Olopatadine—Somnolence—Gabapentin—migraine	7.96e-05	0.0012	CcSEcCtD
Olopatadine—Hypersensitivity—Valproic Acid—migraine	7.96e-05	0.0012	CcSEcCtD
Olopatadine—Feeling abnormal—Timolol—migraine	7.93e-05	0.00119	CcSEcCtD
Olopatadine—Imipramine—HTR7—migraine	7.9e-05	0.0273	CrCbGaD
Olopatadine—Gastrointestinal pain—Timolol—migraine	7.87e-05	0.00118	CcSEcCtD
Olopatadine—Amitriptyline—HTR7—migraine	7.85e-05	0.0272	CrCbGaD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	7.81e-05	0.00117	CcSEcCtD
Olopatadine—Doxepin—HTR1A—migraine	7.78e-05	0.0269	CrCbGaD
Olopatadine—Discomfort—Topiramate—migraine	7.77e-05	0.00117	CcSEcCtD
Olopatadine—Asthenia—Valproic Acid—migraine	7.75e-05	0.00117	CcSEcCtD
Olopatadine—S100B—Toll-Like Receptors Cascades—FOS—migraine	7.75e-05	0.0105	CbGpPWpGaD
Olopatadine—Gastrointestinal disorder—Gabapentin—migraine	7.73e-05	0.00116	CcSEcCtD
Olopatadine—Fatigue—Gabapentin—migraine	7.72e-05	0.00116	CcSEcCtD
Olopatadine—Dry mouth—Topiramate—migraine	7.69e-05	0.00116	CcSEcCtD
Olopatadine—Pain—Gabapentin—migraine	7.66e-05	0.00115	CcSEcCtD
Olopatadine—Acepromazine—HTR2A—migraine	7.66e-05	0.0265	CrCbGaD
Olopatadine—Pruritus—Valproic Acid—migraine	7.64e-05	0.00115	CcSEcCtD
Olopatadine—Amitriptyline—HTR1B—migraine	7.61e-05	0.0263	CrCbGaD
Olopatadine—Abdominal pain—Timolol—migraine	7.6e-05	0.00114	CcSEcCtD
Olopatadine—Body temperature increased—Timolol—migraine	7.6e-05	0.00114	CcSEcCtD
Olopatadine—Clomipramine—SLC6A4—migraine	7.58e-05	0.0262	CrCbGaD
Olopatadine—Oedema—Topiramate—migraine	7.54e-05	0.00113	CcSEcCtD
Olopatadine—Infection—Topiramate—migraine	7.49e-05	0.00113	CcSEcCtD
Olopatadine—Nortriptyline—SLC6A4—migraine	7.4e-05	0.0256	CrCbGaD
Olopatadine—Diarrhoea—Valproic Acid—migraine	7.39e-05	0.00111	CcSEcCtD
Olopatadine—Nervous system disorder—Topiramate—migraine	7.39e-05	0.00111	CcSEcCtD
Olopatadine—Feeling abnormal—Gabapentin—migraine	7.38e-05	0.00111	CcSEcCtD
Olopatadine—Thiothixene—HTR2A—migraine	7.37e-05	0.0255	CrCbGaD
Olopatadine—Gastrointestinal pain—Gabapentin—migraine	7.32e-05	0.0011	CcSEcCtD
Olopatadine—Skin disorder—Topiramate—migraine	7.32e-05	0.0011	CcSEcCtD
Olopatadine—HRH1—Amine ligand-binding receptors—HTR2A—migraine	7.27e-05	0.00982	CbGpPWpGaD
Olopatadine—Dizziness—Valproic Acid—migraine	7.15e-05	0.00107	CcSEcCtD
Olopatadine—Hypersensitivity—Timolol—migraine	7.09e-05	0.00107	CcSEcCtD
Olopatadine—Body temperature increased—Gabapentin—migraine	7.08e-05	0.00106	CcSEcCtD
Olopatadine—Abdominal pain—Gabapentin—migraine	7.08e-05	0.00106	CcSEcCtD
Olopatadine—Asthenia—Timolol—migraine	6.9e-05	0.00104	CcSEcCtD
Olopatadine—Vomiting—Valproic Acid—migraine	6.87e-05	0.00103	CcSEcCtD
Olopatadine—Rash—Valproic Acid—migraine	6.81e-05	0.00102	CcSEcCtD
Olopatadine—Dermatitis—Valproic Acid—migraine	6.81e-05	0.00102	CcSEcCtD
Olopatadine—Pruritus—Timolol—migraine	6.81e-05	0.00102	CcSEcCtD
Olopatadine—Headache—Valproic Acid—migraine	6.77e-05	0.00102	CcSEcCtD
Olopatadine—Dyspnoea—Topiramate—migraine	6.72e-05	0.00101	CcSEcCtD
Olopatadine—Somnolence—Topiramate—migraine	6.7e-05	0.00101	CcSEcCtD
Olopatadine—Doxepin—SLC6A4—migraine	6.64e-05	0.023	CrCbGaD
Olopatadine—Hypersensitivity—Gabapentin—migraine	6.6e-05	0.000992	CcSEcCtD
Olopatadine—Diarrhoea—Timolol—migraine	6.58e-05	0.000989	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Topiramate—migraine	6.51e-05	0.000978	CcSEcCtD
Olopatadine—Fatigue—Topiramate—migraine	6.5e-05	0.000976	CcSEcCtD
Olopatadine—Pain—Topiramate—migraine	6.44e-05	0.000968	CcSEcCtD
Olopatadine—Asthenia—Gabapentin—migraine	6.43e-05	0.000966	CcSEcCtD
Olopatadine—Nausea—Valproic Acid—migraine	6.42e-05	0.000965	CcSEcCtD
Olopatadine—Dizziness—Timolol—migraine	6.36e-05	0.000956	CcSEcCtD
Olopatadine—Pruritus—Gabapentin—migraine	6.34e-05	0.000952	CcSEcCtD
Olopatadine—Imipramine—HTR2C—migraine	6.24e-05	0.0216	CrCbGaD
Olopatadine—Feeling abnormal—Topiramate—migraine	6.21e-05	0.000933	CcSEcCtD
Olopatadine—Amitriptyline—HTR2C—migraine	6.2e-05	0.0215	CrCbGaD
Olopatadine—Gastrointestinal pain—Topiramate—migraine	6.16e-05	0.000926	CcSEcCtD
Olopatadine—Diarrhoea—Gabapentin—migraine	6.13e-05	0.000921	CcSEcCtD
Olopatadine—Vomiting—Timolol—migraine	6.12e-05	0.000919	CcSEcCtD
Olopatadine—Rash—Timolol—migraine	6.06e-05	0.000911	CcSEcCtD
Olopatadine—Dermatitis—Timolol—migraine	6.06e-05	0.000911	CcSEcCtD
Olopatadine—Imipramine—HTR1A—migraine	6.06e-05	0.021	CrCbGaD
Olopatadine—Headache—Timolol—migraine	6.03e-05	0.000906	CcSEcCtD
Olopatadine—Amitriptyline—HTR1A—migraine	6.02e-05	0.0208	CrCbGaD
Olopatadine—Abdominal pain—Topiramate—migraine	5.96e-05	0.000895	CcSEcCtD
Olopatadine—Body temperature increased—Topiramate—migraine	5.96e-05	0.000895	CcSEcCtD
Olopatadine—Dizziness—Gabapentin—migraine	5.92e-05	0.00089	CcSEcCtD
Olopatadine—Clomipramine—HTR2A—migraine	5.82e-05	0.0201	CrCbGaD
Olopatadine—HRH1—G alpha (q) signalling events—HTR2B—migraine	5.81e-05	0.00785	CbGpPWpGaD
Olopatadine—Chlorprothixene—HTR2A—migraine	5.8e-05	0.0201	CrCbGaD
Olopatadine—Nausea—Timolol—migraine	5.71e-05	0.000859	CcSEcCtD
Olopatadine—Vomiting—Gabapentin—migraine	5.7e-05	0.000856	CcSEcCtD
Olopatadine—Nortriptyline—HTR2A—migraine	5.69e-05	0.0197	CrCbGaD
Olopatadine—Rash—Gabapentin—migraine	5.65e-05	0.000849	CcSEcCtD
Olopatadine—Dermatitis—Gabapentin—migraine	5.64e-05	0.000848	CcSEcCtD
Olopatadine—Headache—Gabapentin—migraine	5.61e-05	0.000843	CcSEcCtD
Olopatadine—Hypersensitivity—Topiramate—migraine	5.55e-05	0.000834	CcSEcCtD
Olopatadine—Asthenia—Topiramate—migraine	5.41e-05	0.000813	CcSEcCtD
Olopatadine—Pruritus—Topiramate—migraine	5.33e-05	0.000801	CcSEcCtD
Olopatadine—Nausea—Gabapentin—migraine	5.32e-05	0.0008	CcSEcCtD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	5.19e-05	0.00702	CbGpPWpGaD
Olopatadine—Imipramine—SLC6A4—migraine	5.17e-05	0.0179	CrCbGaD
Olopatadine—Diarrhoea—Topiramate—migraine	5.16e-05	0.000775	CcSEcCtD
Olopatadine—Amitriptyline—SLC6A4—migraine	5.14e-05	0.0178	CrCbGaD
Olopatadine—Doxepin—HTR2A—migraine	5.11e-05	0.0177	CrCbGaD
Olopatadine—Dizziness—Topiramate—migraine	4.98e-05	0.000749	CcSEcCtD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	4.83e-05	0.00653	CbGpPWpGaD
Olopatadine—Vomiting—Topiramate—migraine	4.79e-05	0.00072	CcSEcCtD
Olopatadine—Rash—Topiramate—migraine	4.75e-05	0.000714	CcSEcCtD
Olopatadine—Dermatitis—Topiramate—migraine	4.75e-05	0.000713	CcSEcCtD
Olopatadine—Headache—Topiramate—migraine	4.72e-05	0.000709	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—RAMP1—migraine	4.71e-05	0.00636	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CALCRL—migraine	4.71e-05	0.00636	CbGpPWpGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—FOS—migraine	4.66e-05	0.0063	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	4.49e-05	0.00607	CbGpPWpGaD
Olopatadine—Nausea—Topiramate—migraine	4.48e-05	0.000673	CcSEcCtD
Olopatadine—HRH1—GPCR ligand binding—CALCRL—migraine	4.34e-05	0.00586	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—RAMP1—migraine	4.34e-05	0.00586	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	4.14e-05	0.00559	CbGpPWpGaD
Olopatadine—Imipramine—HTR2A—migraine	3.97e-05	0.0137	CrCbGaD
Olopatadine—Amitriptyline—HTR2A—migraine	3.95e-05	0.0137	CrCbGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	3.85e-05	0.0052	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—TAC1—migraine	3.59e-05	0.00485	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—NPS—migraine	3.59e-05	0.00485	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—HTR2C—migraine	3.52e-05	0.00476	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—EDNRA—migraine	3.42e-05	0.00463	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HTR1D—migraine	3.42e-05	0.00462	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	3.21e-05	0.00434	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	3.21e-05	0.00434	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HTR2B—migraine	3.18e-05	0.0043	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—HTR1D—migraine	3.15e-05	0.00426	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	3.15e-05	0.00425	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	3.06e-05	0.00414	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—HTR2B—migraine	2.93e-05	0.00396	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	2.93e-05	0.00395	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	2.82e-05	0.00381	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—LRP1—migraine	2.8e-05	0.00378	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	2.72e-05	0.00368	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—FOS—migraine	2.65e-05	0.00359	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	2.65e-05	0.00358	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—FOS—migraine	2.51e-05	0.00339	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	2.51e-05	0.00339	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—RAMP1—migraine	2.45e-05	0.00331	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CALCRL—migraine	2.45e-05	0.00331	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	2.41e-05	0.00326	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	2.38e-05	0.00322	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	2.38e-05	0.00321	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	2.38e-05	0.00321	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	2.33e-05	0.00315	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	2.27e-05	0.00306	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—RAMP1—migraine	2.22e-05	0.00301	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CALCRL—migraine	2.22e-05	0.00301	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—HTR2A—migraine	2.16e-05	0.00292	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NOTCH4—migraine	2.15e-05	0.0029	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HTR1B—migraine	2.07e-05	0.0028	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	2.04e-05	0.00276	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HTR1A—migraine	1.99e-05	0.0027	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NPS—migraine	1.96e-05	0.00266	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PGR—migraine	1.96e-05	0.00266	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TAC1—migraine	1.96e-05	0.00266	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	1.93e-05	0.00261	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HTR2C—migraine	1.93e-05	0.0026	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—HTR1B—migraine	1.91e-05	0.00258	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—EDNRA—migraine	1.87e-05	0.00253	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—HTR1A—migraine	1.84e-05	0.00248	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NOTCH3—migraine	1.83e-05	0.00247	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—NPS—migraine	1.81e-05	0.00245	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—TAC1—migraine	1.81e-05	0.00245	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CALCA—migraine	1.8e-05	0.00244	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—HTR1D—migraine	1.78e-05	0.00241	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—HTR2C—migraine	1.77e-05	0.0024	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—EDNRA—migraine	1.73e-05	0.00233	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HTR7—migraine	1.69e-05	0.00228	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	1.67e-05	0.00226	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CALCA—migraine	1.66e-05	0.00225	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—HTR2B—migraine	1.66e-05	0.00224	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HTR1D—migraine	1.62e-05	0.00219	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—HTR7—migraine	1.55e-05	0.0021	CbGpPWpGaD
Olopatadine—S100A12—Immune System—FOS—migraine	1.55e-05	0.00209	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HTR2B—migraine	1.5e-05	0.00203	CbGpPWpGaD
Olopatadine—S100B—Immune System—FOS—migraine	1.46e-05	0.00198	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TGFBR2—migraine	1.45e-05	0.00196	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	1.43e-05	0.00193	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CALCRL—migraine	1.31e-05	0.00178	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RAMP1—migraine	1.31e-05	0.00178	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HTR2A—migraine	1.18e-05	0.0016	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—HTR2A—migraine	1.09e-05	0.00147	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—HTR1B—migraine	1.08e-05	0.00146	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ESR1—migraine	1.05e-05	0.00142	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—HTR1A—migraine	1.04e-05	0.0014	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—NPS—migraine	1.02e-05	0.00138	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—TAC1—migraine	1.02e-05	0.00138	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—HTR2C—migraine	1e-05	0.00136	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HTR1B—migraine	9.79e-06	0.00132	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—EDNRA—migraine	9.75e-06	0.00132	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR1D—migraine	9.55e-06	0.00129	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HTR1A—migraine	9.43e-06	0.00127	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CALCA—migraine	9.39e-06	0.00127	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—TAC1—migraine	9.29e-06	0.00126	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—NPS—migraine	9.29e-06	0.00126	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HTR2C—migraine	9.11e-06	0.00123	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR2B—migraine	8.88e-06	0.0012	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—EDNRA—migraine	8.86e-06	0.0012	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—HTR7—migraine	8.78e-06	0.00119	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CALCA—migraine	8.53e-06	0.00115	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HTR7—migraine	7.98e-06	0.00108	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—LRP1—migraine	7.82e-06	0.00106	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—HTR2A—migraine	6.15e-06	0.000832	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NOTCH4—migraine	6e-06	0.000811	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR1B—migraine	5.79e-06	0.000782	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HTR2A—migraine	5.59e-06	0.000755	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR1A—migraine	5.57e-06	0.000753	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NPS—migraine	5.48e-06	0.000741	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TAC1—migraine	5.48e-06	0.000741	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PGR—migraine	5.48e-06	0.000741	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR2C—migraine	5.38e-06	0.000727	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EDNRA—migraine	5.23e-06	0.000707	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NOTCH3—migraine	5.1e-06	0.000689	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CALCA—migraine	5.04e-06	0.000681	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR7—migraine	4.71e-06	0.000637	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CACNA1A—migraine	4.63e-06	0.000626	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TGFBR2—migraine	4.06e-06	0.000548	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR2A—migraine	3.3e-06	0.000446	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ESR1—migraine	2.93e-06	0.000396	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—MTHFR—migraine	1.53e-06	0.000207	CbGpPWpGaD
